Sanofi from PharmaTimes, Pharmafile, Pharmaceutical Executive - Journalist Profile

	Profile	Recent Articles on Subject
1	Sanofi PharmaTimes	Passion project - 9 months ago AstraZeneca and Sanofi’s Beyfortus approved in China - 11 months ago Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment - 12 months ago Sanofi shares new data for long-term efficacy of Nexviazyme for Pompe disease treatment - about 1 year ago Janssen and Sanofi enter agreement for potential vaccine programme - about 1 year ago Sanofi, Teva Ink Deal to Develop Inflammatory Bowel Disease Treatment - about 1 year ago Sanofi and Teva partner for development of inflammatory bowel disease treatment - about 1 year ago Sanofi, Janssen to Collaborate on Extraintestinal Pathogenic E. Coli Vaccine - about 1 year ago Pharmanovia acquires CNS portfolio from Sanofi - about 1 year ago
2	AstraZeneca Pharmafile	AstraZeneca and Sanofi’s Beyfortus approved in China - 11 months ago
3	Regeneron Pharmafile	Sanofi and Regeneron share results from phase 3 trial for Dupixent as COPD treatment - 12 months ago
4	Janssen Pharmafile	Janssen and Sanofi enter agreement for potential vaccine programme - about 1 year ago Sanofi, Janssen to Collaborate on Extraintestinal Pathogenic E. Coli Vaccine - about 1 year ago
5	Teva Pharmaceuticals Pharmaceutical Executive	Sanofi, Teva Ink Deal to Develop Inflammatory Bowel Disease Treatment - about 1 year ago
6	Teva Pharmafile Global pharmaceutical company. healthcarepharmaceuticals	Sanofi and Teva partner for development of inflammatory bowel disease treatment - about 1 year ago
7	Pharmanovia Pharmafile	Pharmanovia acquires CNS portfolio from Sanofi - about 1 year ago